Mirati Therapeutics Inc. buy Midas
Start price
10.12.20
/
50%
€197.70
Target price
10.12.21
-
Performance (%)
-27.04%
End price
09.04.21
€144.25
Summary
This prediction ended on 09.04.21 with a price of €144.25. The prediction for Mirati Therapeutics Inc. disappointed with a performance of -27.04%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1,86 % | -1,62 % | 0,64 % | 51,03 % |
| iShares Nasdaq 100 | -3,32 % | 3,32 % | 32,00 % | 86,51 % |
| iShares Nikkei 225® | -2,30 % | 3,44 % | 51,01 % | 58,81 % |
| iShares S&P 500 | -1,31 % | 2,44 % | 23,01 % | 65,41 % |
Comments by Midas for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Buy Mirati Therapeutics Inc.